Company Announcement: MatOrtho Welcomes Connection Capital as an Investor in its Next Phase of Growth
We are delighted to confirm that Connection Capital joins MatOrtho® at an exciting time in the company’s lifespan. The management team will be supported by Mr Michael Coupland who has been appointed as the Investor Director and Mr Simon Cartmell OBE, who has experience in the medical field and has joined the board as a Non-Executive Director.
Alongside the need to support the natural growth of the business, this decision will also underpin our strategic goals to develop and supply our technologies globally.
Since the company was founded in 2010, MatOrtho® has continued the pioneering work of its predecessor, Finsbury Orthopaedics, in producing and developing products that have been the envy of our competitors. The resilience and effort we have demonstrated in often challenging regulatory environments and against the resolute activity from the ‘big fish’ has resulted in some of the best surgeons internationally trusting our company, products, concepts, and philosophies.
This investment will allow us to scale up our production and accelerate international expansion into new and existing markets. It will also support our research and development projects as the company continues to develop the next generations of implant technologies.
Whilst this all takes place it is inevitable that some changes will transpire, however, it is without question that our Chairman, Mike Tuke, remains at the helm and will continue his role in providing ideas and direction to the business. Mike’s vision to continue the pioneering work of more than four decades lives on and MatOrtho® remains focused on delivering against our unwavering commitment to achieve the best that patients can get in terms of device longevity, satisfaction, and a return to long and active life.